Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Skinvisible, Inc. (SKVI) is “One to Watch”
- Patented technology enhances how topical and transdermal drugs and skin care products are delivered
- Polymer delivery vehicle can be tailored to almost any type of molecule including the medicinal components of hemp and marijuana
- 14 patents granted in the U.S. and internationally
- $65 billion market in dermatology, pharmaceutical and other healthcare industries offers strong growth opportunity
Skinvisible, Inc. (OTCQB: SKVI), through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible’s formulations to sell their own patented product and combat generic competitors.
A prescription dermatology product can generate $100 million or more a year, with the potential to lose 50-90% of that revenue when it goes off patent. Preserving that revenue is why the licensing of a product made with Invisicare is a very desirable option for many companies. The Company has developed a pipeline of 40 products using Invisicare, with a primary focus on optimizing the performance and increasing the value of “gold standard” dermatology drugs and licensing them to international and multi-national companies in the pharmaceutical, over-the-counter and cosmeceutical markets.
Invisicare® is a high performance topical and transdermal delivery system which enhances the delivery of drugs and other ingredients to and through the skin. The key to Skinvisible’s patented technology and trademarked Invisicare® family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Invisicare® can be a key component of life cycle management, extending the life with a new patent-protected product, dramatically expanding the company’s revenue stream.
Independent studies of Invisicare ® have shown the following benefits:
- Active ingredients stay on the skin for up to four hours or more and resist wash off and rub off.
- Delivery method results in improved efficacy, reduced skin irritation and lower required dosage.
- Unique formulations are non-drying and provide the ability to control the release of active ingredients.
- Products form a protective barrier, which means normal skin respiration and perspiration occur and the product wears off as part of the skin’s natural exfoliation process.
Terry Howlett, President, founder and CEO of Skinvisible Inc., said the Company has more than 15 years of scientific research and product development experience. All development is conducted using stringent pharmaceutical standards. The Company has licensed a number of its formulations including a prescription hemorrhoid cream in the USA, its anti-aging Kintari® line of products and DermSafe®, its non-alcohol hand sanitizer to a licensee in China. Producing licensed products for the booming cannabis industry is also an important element of the company’s business strategy.
Skinvisible’s foray into the rapidly expanding market for medicinal and recreational cannabis products is already underway with the development of the company’s first hemp-derived CBD (cannabidiol) products. Skinvisible has negotiated an exclusive licensing deal in Canada with Canopy Growth Corporation, one of the world’s leading cannabis companies. As part of the company’s overall growth strategy, Skinvisible is also negotiating with a Licensed Producer in Las Vegas where Skinvisible scientists will develop THC (tetrahydrocannabinol) products for the legal recreational and medical marijuana market for the USA. Notably, Skinvisible is actively pursuing potential licensees through-out the world where medical cannabis is legal. These licensees will have the exclusive right to manufacture and distribute Skinvisible’s cannabis products within their territory.
“We are excited about the results we are already seeing just with our hemp-derived CBD products,” Howlett says. “Our science shows that our CBD products release almost four times that of market leaders and our transdermal product had an 81% penetration rate at 6 hours. These results are significant and provide the difference between ordinary cannabis products and ones enhanced by Invisicare.”
The Company’s business model includes out-licensing its formulations for a development fee, license fee and on-going royalties in addition to selling its Invisicare polymers to its licensees.
For more information, visit the company’s website at www.Skinvisible.com
...LGNDZ @0.005 up 43% with just 140,000 shares..
Think this buying is due to the 8k released couple of days ago about merger plan.
add to Watch
http://www.otcmarkets.com/stock/LGNDZ/filings
the 8K direct link
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12312802
ZMRK 52 week lows 400 mill a/s pink current!
Did u read the or top to bottom
$AVEW Friday sale .0024 won't last cheap!
Could Very Well be~ Lotta $ONCI Volume yesterday General~ that Say's PAY ATTENTION there,imo~ Best always~
imo
Flex
$MAXD Second RUN off the .001's BUY alert a few weeks ago! these are Great Trades and REPEAT! $LPPI I LOVE this Seller even tho its a trickle and each ones a fee Flex will TAKE EM'!
all,imo
Flex
Perfect buy in right here ONCI .125
$EPAZ About Epazz, Inc. (www.epazz.com) Epazz, Inc. is a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher-education institutions, and the public sector.
Epazz BoxesOS™ v3.0 is the complete web-based business software package for small- to mid-sized businesses, Fortune 500 enterprises, government agencies, and higher-education institutions.
BoxesOS provides many web-based applications that organizations must otherwise buy separately. Epazz's other products are AgentPower™, a workforce management software, and AutoHire™, an applicant-tracking system.
Epazz Launches Reg CF Crowdfunding Campaign to Market Bitcoin Cannabis Payment Mobile App (ZenaPay) and Other Cloud Software Products
https://finance.yahoo.com/news/epazz-launches-reg-cf-crowdfunding-130000801.html
PFWI!!!!!!!!!!!!!!!!$$$$$$$$$$$$$$$ chart
Afternoon General~I would have ,BUT, the Doc advised against IT! Many Sold $ONCI before the close yesterday and Hoped they could keep that going as they did without Support after tyhe News dropped~ Guess Eyes finally Opened~ See you at the Next NATION Sensation! imo
Flex
CNXS & BYSD Chatter as SANP & SKYF continue to move up #Bitcoin Craze Continues!
UNDER RADAR -- SAKL@0.001 New Acquisition of 20+ Mill company, 211Mill O/S
$DATI ~ Fundanna is a Trailblazer in the Cannabis Crowdfunding Space
https://www.crowdfundinsider.com/2017/10/122604-whats-going-cannabis-equity-crowdfunding
The UHLN NOL = .03+ per share...
Based on UHLN having $10,378,495 for their Federal and State Net Operating Loss (NOL)... and 345,450,166 shares for its Outstanding Shares (OS)... this adds an amount of .03+ per share for one years worth of valuation towards a company's profitable Earnings Per Share (EPS) of which could be spread out, but will expire commencing in 2030.
In my opinion, this is why something very very profitable will be coming into UHLN. The UHLN public entity is too valuable with too much potential to not do something huge with it as I believe that the controlling party is very aware of this. This is why I believe it is only a matter of time before we learn of the major operations that will be the catalyst to graduate UHLN to the next few levels.
v/r
Sterling
ENUM .0068 50k Left, 3 Huge Cancer Drugs Ready for TESTING!!
ENUM .0068 $67M REVENUES Potential for future development milestones of up to an aggregate of $37.8 million and net sales
milestone payments of up to an aggregate of $67.5 million, each upon achievement of specified
targets.
– Potential for royalties in the low-to-lower middle single digits as a percentage of net sales,
depending on the amount of net sales in applicable years.
• Pieris has an option until May 31, 2017 to license specified Enumeral patent rights and know-how
covering two additional undisclosed antibody programs on the same terms and conditions as for the
388D4 antibody. Pieris will pay Enumeral additional undisclosed license fees in the event that Pieris
exercises one or both of these options.
• Enumeral can continue to develop or partner the 388D4 PD-1 program, as well as the other antibody
programs subject to the option described above, provided that Enumeral has agreed not to conduct,
or assist third parties in conducting, activities that involve an antibody licensed under the Pieris
License and Transfer Agreement fused with or linked to one or more Anticalin proteins in the field of
oncology.
26
OTCQB:
ENUM .0068 MERCK: collaboration with a leading immuno-oncology pharmaceutical company
– Focused on using Enumeral's platform to interrogate the tumor microenvironment in colorectal cancer
tissues to identify functional cellular responses to therapies being developed by Merck
– R&D funding and undisclosed milestone payments
– Merck has exclusive rights to data related to its proprietary compounds
– ENUM has achieved first milestone in the collaboration
– Expanded scope of work to include non-small cell lung cancer
• NCI: awarded Phase 2 contract in September 2014 for ~$1 million over two years
– Automation of human tissue immuno-oncology profiling
– Opens door to broader pipeline and potentially accelerated development
– Collaboration with leading scientists:
– Jedd Wolchok’s group at MSKCC - genetic basis for response to checkpoint inhibitors and novel immunotherapeutics
– Doug Kwon’s group at MGH/Ragon Institute - pioneering techniques for single cell immune cell analysis in biopsy
SANP getting ready for the 0011 break to new HOD. Trading beautifully!
BFRE sure can!
AEPP thin back to the high of day
RBNW News .0112
LED Lites USA In Talks to Establish Three New Sales and Distribution Centers To Serve the Los Angeles, San Diego and Mexican Markets
LAS VEGAS, NV -- (Marketwired) -- 10/06/17 -- LED Lites USA, a division of Renewable Energy and Power, Inc., (OTC PINK: RBNW), a diversified corporation with markets in energy-saving technologies of LED lighting, solar and wind energy, is in talks to establish three new Sales and Distribution Centers serving Los Angeles, San Diego and Mexico for the company's LED lighting products.
"The enthusiastic response we received for our LED line of products at the recent WESTEC Trade Show at the L.A. Convention Center convinced us that distribution centers serving the Southern West Coast area was something we should establish as quickly as possible," said company president Donald MacIntyre. "Consequently, we are now in talks with a number of companies to stock and distribute our product in the Los Angeles, San Diego and Mexican markets. We're keying on companies with the expertise to assist our customers on-site for their new or retrofit needs, rather than just selling product."
LED lighting lowers energy costs directly and by lowering cooling bills as less heat is generated by LEDs. The expertise LED Lites USA provides, for both new and retrofit LED Lighting, allows businesses to take advantage of these savings with the lowest costs for the most advanced LED products, and with the least disruption to their on-going business.
LED Lites also provides learning material, both directly and through its website and social media, to those interested in learning more about LED Lighting. LED Lites USA constantly evaluates the LEDs being used in the products it provides, stocking those with the newest LEDs that provide the most effective illumination at the lowest cost. Upgrades to imported product increase the reliability and ease of installation, making the products of LED Lites USA stand out as manufactured in the USA from domestic and imported components rather than just passing on products supplied from overseas.
Renewable Energy and Power, Inc.'s website, www.reappower.com, illustrates the important services and products Renewable Energy and Power, Inc. (REAP) provides to the Green Energy market to make it competitive with fossil fuels by employing proprietary new technologies in combination with existing solar and wind-power electric generation and LED lighting. REAP functions in both domestic and international markets that are in vigorous growth stages with long-term prospects. Federal and state legislation in the United States, including many tax incentives, are driving businesses and consumers to replace older technologies with the new solar and LED alternatives offered by REAP.
Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Bruce Macintyre
702-685-9524
brucem@reappower.com
Source: LED Lites USA
BFRE thin, can move imo
ENUM .0068 was $1.50, Management from MERCK, WYETH, NOVARTIS, SANOFI, UPJOHN and More, Huge!!
summer was alright
$ENUM .0068 Up Huge CANCER Stock, PRESENTATION & TRANSLATION POWERPOINTS >>
http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjU3MDY5fENoaWxkSUQ9MzYzMDI2fFR5cGU9MQ==&t=1
http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjU3MDY4fENoaWxkSUQ9MzYzMDI1fFR5cGU9MQ==&t=1
DOLV .05's about to hit...
$ENUM .0068 Up Partner's with Leading Pharmaceutical Companies Sanofi NYSE:SNY, Crucell NASDAQ:CRXL, Celgene NASDAQ:CELG and Novartis NYSE:NVS https://t.co/qK8mKDmVN0
Thank god summer is over!! Otc back up and running making money
ONCI DUDE BUY DORK
MAXD sells and it upticks they want this higher
MAXD @.0019 Wow !!!
Dam Now a double prinT just as I say that! ugh~ $MNZO gotta see this off the dip,imo
Flex
$MNZO Anyone trading this that can share me the status??? Looks interesting here as it always has volume?? imo
Flex
SOUPQ SILENTLY MOVING. HAVE-TO-BE OUT OF YOUR MIND IF YOURE NOT LOADING HERE
SOUPQ WILL HAVE THE LARGEST REVERSE MERGER IN THE OTC THIS YEAR. ALL THE SIGNS HAVE BEEN POINTED OUT FED TO YOU IN A SPOON to your mouths but people feel they can shake us with YABA DABA DOO DOO.
BEAUTIFUL POST BELOW. SOUPQ IS what everyone who trades in the OTC DREAMS ABOUT, it is the reason you trade the otc. Find an EXRREMELY UNDERVALUED GEM, do your DD, get in cheap, and watch it run to PLUTO. WC, JR FREEDMAN, JOE HAGAN... have done everything to let LONGS KNOW that a reverse merger is coming BY THEIR ACTIONS but scream WE ARE GOING TO DO A REVERSE MERGER INTO SOUPQ!!!
GREAT POST BELOW. We are looking at a future $1 stock with SOUPQ
"Soupman is up next!
See Investview, the latest company Joseph Hagan and WealthColony reverse merged into in April 2017. Current market cap of 135 million with stock price trading 15x higher post-reverse merge.
See Hagan’s linked in... “Reverse Merger” is one of his specialties :)
https://www.sec.gov/Archives/edgar/data/862651/000114420417040363/v472287_sc13d.htm
Item 3. Source or Amount of Funds or Other Consideration.
Wealth Colony LLC acquired 101,900,321 common shares of the Company in connection with the Contribution Agreement entered between the Issuer and the members of Wealth Generators, LCC, a limited liability company (“Wealth Generators”), pursuant to which the Wealth Generators Members agreed to contribute 100% of the outstanding securities of Wealth Generators in exchange for an aggregate of 1,358,670,942 shares of the common stock of the Issuer. The closing of the Wealth Generators Contribution agreement occurred after close of business on March 31, 2017, therefore, effective April 1, 2017, Wealth Generators became a wholly owned subsidiary of the Company and Wealth Colony thereby acquired 101, 900,321 common shares of the Issuer.
Item 4. Purpose of Transaction.
The purpose of the transaction was to effect a “reverse merger” in which the members of Wealth Generators acquired a majority of Investview’s common stock thus succeeding in assuming the operations of Investview, Inc. going forward. "
Another simple straight forward, no brianer post below
It has less to do with assets but rather more to do with value and cost savings.
"What value does SOUP shell have to GBI?
It is already a publicly traded company. From personal experience, IPO’s are very expensive and time consuming. Fees paid to the underwriter’s and professional fees paid to the company's external auditors and SEC counsel and other partners involved can will up quickly into the multi-millions. Then there are the costs for exchange listing fees, press releases, stock transfer agents, public relations costs which could be another million or more.
Refer to below:
http://www.truecapitalfp.com/article/reverse-merger/
"Why Would a Company Consider a Reverse Takeover?"
"...it simplifies the process of going public by eliminating the need for a lengthy planning process and flawless execution. In addition, it separates the tasks of raising capital and going public, making the entire process easier by allowing managers to focus on one task at a time. Another reason the reverse takeover can be useful is that the shell company the private entity purchases can be selected or engineered to have just the organizational structure the private entity wants its publicly traded incarnation to have, further simplifying long-term business prospects."
Lets not forget that WC’s shares are locked up in that shell – over 194 million of them. Lastly, there is the ticker SOUP which represents the brand on the exchange. I would say SOUPQ has value to GBI. "
SOUPQ COULD CHANGE A LOT OF PEOPLES ZIPCODES THESE CHEAPIES WONT LAST
SOUPQ IS IN GREAT HANDS, it has a WONDERFUL PRODUCT, now it has a $750 million HEDGEFUND OWNING IT...YES A HEDGEFUND. Do you know what HEDGEFUNNDS do? You may not but my guess is they know a thing or 2 about how to increase the value of a stock. FELLAS SOUPQ was trading at $2.40 once upon a time WITHOUT A HEDGEFUND, you think it can't make it back and exceed that price? Or maybe even reach HALF if that price (that's $1.20 in case you can't calculate that)? I say ABSOLUTELY. SOUPQ IS VERY VERY RARE FOLKS. We are so Golden its not even funny. WARCH US TGE NEXT 2 WEEKS. I won't be able to sleep all weekend. PLEASE SPREAD THE ARTICLES, spread the word on SOUPQ. We are tapping on Monday. SOUPQ
$SOUPQ: Get to know JR-FreedMAN.... A Money Maker
Increased Revenues from $38Million to $700Million.
So he can increase SOUPMAN's revenues from $1.9Million/yr to $40Million/yr?
JR Freedman knows how to put together a Robust Business PLAN.
Allis-Chalmers merged with SeaWell in 2011.
http://archerwell.com/seaw-merger-with-allis-chalmers-energy-inc/
Who does Freedman wanna merge Soupman with ?
$SOUPQ: Also remember... JR-Freedman recapitalized Petro-River OIL
The guy is a Seasoned Veteran and Master Negotiator.
He knows what he's doing and his track record and reputation proceed him.
Ride those Coat-TAILS !!!!!!!!
$SOUPQ: Annual Sales about to SkyRocket under JR-Freedman
Jamieson Karson was a DUD.... to the curb with that Imbecile.
Bring in the Big Guns.... JR-Freedman.
SEASONED PRO. REAL PROVEN LEADERSHIP.
Everyone tells you that before you look at a COMPANY... Look at who's leading it.
Reed Hastings, Mark Benioff, Indira Nooyi, Mark Hurd, etc. etc.
JR-Freedman is of that Calibre
Raised almost $10Billion in various Capital Market Transaction.
He has ample access to Capital.
Read the RESUME... Use your own Judgement.
Don't listen to the JOKERS showing up today trying to bring down the Share PRICE with Scare Tactics.
https://www.slideshare.net/JeffreyRFreedman/jrf-revised-resume-117
HVCW 0018 +20% 220M O/S.. 5000% TICKET IMO... CHECK IT OUT..... STILL BOTTOM RANGE
1. $5.9M REVENUE
2. $5M ASSETS
3. 5 FILINGS OUT
4. NEW CEO
5. WENT UP PINK CURRENT BY OTC MARKETS
6. REVENUE INCREASE AND HVCW EXPANDING
7. $400.000 M-CAP BY MONSTA $5.9M REVS
8. EXTREMLY UNDERVALUED!
9. NEW REVULATION START NOW AND HVCW JUST
WARM UP SO FAR.
10. EXPECT COUPLE OF BIG NEWS NEXT
DAYS/WEEK
11. $05 $0.1 PPS MY TARGET FOR HVCW
12. ABOUT 130M FLOAT / 220M O/S CONFIRMED
HEME 12% 001, 11% Thur, 300% Wed and THIN!
NSAV looks like she’s about to uptick imo
Followers
|
9993
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
4967307
|
Created
|
01/10/04
|
Type
|
Free
|
Moderator i_like_bb_stock | |||
Assistants koolmc MOMO vantillian Rainer StockRocket |
Goal: TO PROVIDE A FORUM FOR BOTH EXPERIENCED AND NOVICE TRADERS TO SHARE THEIR OPINIONS ON STOCKS TRADED ON THE BULLETIN BOARD OR PINK SHEET MARKETS, AS WELL AS THE BIG BOARDS. FUNDAMENTALS, NEWS, RUMORS ARE WELCOME, BUT FOR THE MOST PART, THIS BOARD WILL BE TO SHARE TECHNICAL ANALYSIS. TIMING IS EVERYTHING WHEN BUYING OR SELLING A STOCK, AND TECHNICAL ANALYSIS CAN OFTEN DETERMINE THE APPROPRIATE ACTION TO TAKE. ALL TECHNICAL INDICATORS ARE WELCOME. FOR NOVICE TRADERS, QUESTIONS ARE WELCOMED, AND SOMEONE WILL TRY AND HELP YOU WITH THE ANSWER. I WAS ONCE A NOVICE TRADER, AND KNOW THAT GUIDANCE WOULD HAVE HELPED ME SEVERAL YEARS AGO, SO I WOULD LIKE TO HELP YOU AS MUCH AS POSSIBLE. -- i_like_bb_stock |
Rules:1) Spam of any kind will not be tolerated2) There will be times when posters are not in agreement, that is healthy, but please no personal attacks. 3) No specific price preference for the board but these are mostly OTC stocks. 4) Volume is the blood in a stock's veins, so I typically prefer stocks with historical volume, otherwise there is little liquidity for selling the stock if need be. 5) Posting charts and annotations if you have a service that provides it are highly welcome since this provides support for your buy/sell/hold signal. 6) As always, do your due diligence, and remember that there is high risk in these types of stocks. Never trade with money that you cannot afford to loose. 7) If the post is Off Topic, please post with OT prefacing the post. |
Some relevent info:1) For SEC filings I use www.otcmarkets.com.2) For daily charts I use www.stockcharts.com. There is a free service which is time delayed, and then different levels of paid service. 3) To post a chart from stockcharts.com, right click on the chart, click "Copy Image URL". Within the post, right click and click Paste. Remove "http://" then place the chart URL between these tags [*chart]URL[*/chart] (remove the asterisks) 4) For level II, there are various services, IHUB has its own services, individual brokers as well, I use TDAmeritrade, which offers free level II if you have an account. 5) I use equityfeed.com which is critical for any otc trader. It has level II as well, real time news, scanning, and a plethora of things that are needed as a trader. There are various price points based on your needs. 6) For a great listing of stock terms or investor information, use www.investopedia.com or www.investorwords.com. 7) For more info on chart formations, see http://www.chartpatterns.com and http://thepatternsite.com. 8) To find splits, symbol changes etc., use http://otce.finra.org/DailyList 9) Remember also to sell into strength and buy into weakness. When possible, try not to sell at the bid. When a stock is strong, you can usually at least get filled somewhere between the bid/ask, selling at the bid will often hurt the stock, since the market makers make take the bid down further afterwards. 10) For info on stockcharts.com, see the Stockcharts board on the Hub: http://www.investorshub.com/boards/board.asp?board_id=1277 |
Posts Today
|
1
|
Posts (Total)
|
4967307
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |